Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: jackie who wrote (1341)	12/10/1999 10:59:00 PM
From: Chuca Marsh	Read Replies (1) \| Respond to of 1501

Ask FAKE: SEE IZP - - Company Website inflazyme.com Trade times are local to the exchange. News times are Pacific. Bid/ask/vol sizes in thousands. Sym-X Bid - Ask Last Chg % Vol $Vol #tr Open-Hi-Lo Year Hi-Lo last trade News delay IZP - T 13.0 1.06 · 1.10 7.0 1.10 +0.05 4.8 38.6 41 27 1.06 1.10 1.05 1.65 0.97 Dec 10 15:39 Nov 15 15 min RT 2¢ IZP - V 10.0 1.00 · 1.86 2.4 1.05 0.0 0 1 0.00 0.00 0.00 2.20 0.00 Dec 10 12:13 Nov 15 15 min RT 2¢ Click the symbol for more quote detail and fundamental data Forum - Trade Workstation - Market Depth - 1yr Chart - 3months - JAVA Charts - Company - 1yr Bulletins - Historical - Options - Short - Portfolio Last 10 trades today Time X Price Chg Vol Buyer Seller 15:39:10 T 1.100 .050 1000 85 ScotiaMcLeod 39 Merrill Lynch 15:18:50 T 1.090 .040 3000 81 Gordon 36 Latimer 14:33:20 T 1.060 .010 2000 81 Gordon 7 Green Line 14:02:00 T 1.050 .000 4800 7 Green Line 2 DS 14:02:00 T 1.050 .000 4700 59 PI 2 DS 14:02:00 T 1.060 .010 3000 36 Latimer 2 DS 13:53:00 T 1.090 .040 600 79 Gundy 59 PI 13:53:00 T 1.090 .040 2400 79 Gundy 36 Latimer 13:47:50 T 1.090 .040 1400 7 Green Line 59 PI 13:01:50 T 1.050 .000 2200 7 Green Line 6 Union canada-stockwatch.com Let's see if anyone pays Market tomorrow. Interesting...My $1.72 Buy Back In Nothwithstanding! Chucka

To: jackie who wrote (1341)	12/11/1999 7:21:00 PM
From: Sean Janzen	Read Replies (1) \| Respond to of 1501

Off Topic It is my understanding that typically there are restrictions on shares traded. It doesn't take a lot of buying to drive the price upwards. It's probably too premature to talk about anything similar happening with IZP. I was glad to see a biotech initiate a successful IPO. Maybe IZP can pull off a similar type financing in a few years after they get a few licensing deals under their belt. Here are a few more details on Tularik. After the offering, there will be about 41.3 million shares outstanding in the company, according to the filing. Subject 31221 Our product pipeline includes two cancer drug candidates in clinical testing, one cancer drug candidate for which an investigational new drug application, known as an IND, has been filed, one preclinical anti-CMV drug candidate and 14 early and advanced drug leads in our other programs. To date, we have: . identified numerous validated targets and other novel proteins that regulate the expression of disease-causing genes; . established more than 80 biochemical and cell-based assays for high throughput screening, known as HTS; . conducted more than 15 million drug screens using a library of more than 500,000 distinct compounds and natural products; . identified seven compounds that are early leads, seven compounds that are being optimized by chemists, one compound that is in preclinical development, one anti-cancer drug candidate for which we have filed an IND application and one anti-cancer drug candidate that is in phase 1 clinical trials; and . obtained a license for an anti-cancer drug candidate that we expect to enter phase 2 clinical trials in 2000. biz.yahoo.com We currently have corporate collaborations in six of our research programs